Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

RaySearch Laboratories Board/Management Information 2021

Sep 3, 2021

3101_rns_2021-09-03_0a2814b0-466e-41ba-991d-1fa249e8a225.pdf

Board/Management Information

Open in viewer

Opens in your device viewer

PRESS RELEASE STOCKHOLM, 3 SEPTEMBER 2021

RAYSEARCH'S CFO PETER THYSELL HAS RESIGNED

RaySearch Laboratories AB (publ) CFO Peter Thysell has resigned from his role to take on the role of CFO of another company. Peter Thysell will continue in his current role during the notice period of three months to ensure an orderly transition until a new CFO takes over. The process to recruit his successor has begun.

"We thank Peter for his contributions to RaySearch during the past six years and wish him the best in his new endeavours" says Johan Löf, CEO of RaySearch.

For further information, please contact:

Johan Löf, CEO Telephone: +46 8 510 530 00 Email: [email protected]

About RaySearch

RaySearch is a medical technology company that develops innovative software solutions to improve cancer treatments. The company markets worldwide its treatment planning system RayStation and the oncology information system RayCare*. In December 2020, the company also launched a new treatment control system, RayCommand, as well as the data analytics system RayIntelligence. Over 2,600 clinics in more than 65 countries use RaySearch software to improve life and outcomes for patients. The company was founded in 2000 and the share has been listed on Nasdaq Stockholm since 2003.

More information about RaySearch is available at www.raysearchlabs.com

* Subject to regulatory clearance in some markets.